Results 181 to 190 of about 57,075 (256)

Intravesical Delivery of P21 mRNA–Loaded Lipid Nanoparticles as a Tumor Suppressor Replacement Therapy for Bladder Cancer

open access: yesThe FASEB Journal, Volume 40, Issue 10, 31 May 2026.
Intravesical delivery of p21 mRNA‐loaded lipid nanoparticles (p21‐LNP) restores the tumor suppressor p21 in bladder cancer. Localized p21 expression directly induces cell cycle arrest, DNA damage and apoptosis, and ultimately inhibits orthotopic tumor growth with minimal systemic distribution and favorable safety.
Jie Zeng   +3 more
wiley   +1 more source

Addition of immune checkpoint inhibitors to intravesical BCG for high-risk BCG-naïve non-muscle invasive bladder cancer: Systematic review and meta-analysis. [PDF]

open access: yesBJUI Compass
Titus RS   +12 more
europepmc   +1 more source

Time Course Characterization of Protective Immune Responses Following BCG Vaccination in BALB/c Mice. [PDF]

open access: yesPathogens
Kim HH   +10 more
europepmc   +1 more source

BCG vaccination in Korea, Japan, and Taiwan: Current status and future perspectives. [PDF]

open access: yesHum Vaccin Immunother
Choe YJ   +4 more
europepmc   +1 more source

Efficacy and safety of RC48 alone or combined with PD-1 inhibitors in high-risk non-muscle invasive bladder cancer. [PDF]

open access: yesSci Rep
Guo X   +13 more
europepmc   +1 more source

The influence of murine cytomegalovirus infection on susceptibility to mycobacterial infection. [PDF]

open access: yesiScience
Li S   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy